Understanding pain in inflammatory joint diseases

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is an exploratory, longitudinal observational project enrolling patients with inflammatory joint diseases who initiate or switch biological or targeted synthetic DMARD therapy. Participants will undergo repeated clinical assessments over time to identify phenotypes and endotypes of chronic pain, with a special focus on measures of central sensitization and cognitive functioning. The study will examine how these pain subtypes and risk factors relate to disease activity, treatment response, and daily functioning. Collected data aim to clarify causes and consequences of chronic pain and guide more personalized pain-management approaches.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* All patients who initiate or switch biological or targeted synthetic DMARDs

Exclusion Criteria:

* None

Where it's running

• Diakonhjemmet Hospital
  Oslo, Norway Recruiting

Study contacts

• Study coordinator: Ida K Haugen, MD PhD
• Email: ida.k.haugen@gmail.com
• Phone: +47 95859884

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Pain patterns in rheumatic diseases: see if pain works differently in patients and healthy people

  This observational study tests how pain is experienced and measured in people with rheumatic diseases compared with healthy volunteers.

  Recruiting National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT07829497

• Validation of the 2025 Axial Spondyloarthritis Classification Criteria in Chinese patients

  This study tests whether the 2025 ASAS-SPARTAN criteria correctly classify axial spondyloarthritis in adults with chronic back pain in China.

  Recruiting Chinese PLA General Hospital · Beijing, Beijing Municipality · NCT07724847

• Guselkumab in Breast Milk for Lactating Women on Guselkumab

  This study tests how much guselkumab is present in the breast milk of lactating women who are already receiving guselkumab for their approved conditions.

  Recruiting Phase 4 Janssen Research & Development, LLC · Chapel Hill, North Carolina · NCT07654751

• One-year guselkumab use in adults with psoriatic arthritis

  This project will see how long adults with psoriatic arthritis stay on guselkumab over one year when prescribed as part of routine care.

  Recruiting Janssen-Cilag Ltd. · Lille · NCT07532226

• Ultrasound Before Corticosteroid Injection for Arthritis

  This trial tests whether applying ultrasound before a corticosteroid joint injection helps improve arthritis symptoms in adults with limb arthritis who need an injection.

  Recruiting Taichung Veterans General Hospital · Taichung · NCT07363876

• Ultralow-dose PET scan to detect bone activity with 18F‑NaF

  This trial tests whether a new high-sensitivity PET scan using a tiny amount of 18F‑sodium fluoride can produce clear bone images in adults with or without bone disease while cutting radiation exposure by 10–100 times.

  Recruiting Phase 2 Nuclear Imaging Institute · Englewood, New Jersey and 1 other locations · NCT07284563

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.